127 results on '"Wirjanata, Grennady"'
Search Results
2. Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV000848
3. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity
4. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
5. Sterile protection againstP. vivaxmalaria by repeated blood stage infection in theAotusmonkey model
6. Author Reply to Peer Reviews of Sterile protection against Plasmodium vivax malaria by repeated blood stage infection in the Aotus monkey model
7. Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV00848
8. On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity
9. Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome
10. A novel multiple-stage antimalarial agent that inhibits protein synthesis
11. KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
12. Sterile protection against P. vivax malaria by repeated blood stage infection in the Aotus monkey model.
13. A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples
14. RepeatedPlasmodium vivaxblood stage infection provides sterile protection against homologous challenge in non-human primates
15. Short tandem repeat polymorphism in the promoter region of cyclophilin 19B drives its transcriptional upregulation and contributes to drug resistance in the malaria parasite Plasmodium falciparum
16. Identification of an Inhibitory Pocket in Falcilysin Bound by Chloroquine Provides a New Avenue for Malaria Drug Development
17. The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance
18. Identification of an inhibitory pocket in falcilysin bound by chloroquine provides a new avenue for malaria drug development
19. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling
20. A comprehensive RNA handling and transcriptomics guide for high-throughput processing of Plasmodium blood-stage samples
21. Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
22. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
23. Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis
24. 3,3′-Disubstituted 5,5′-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity
25. Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
26. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”
27. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes
28. UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria
29. Passively versus Actively Detected Malaria: Similar Genetic Diversity but Different Complexity of Infection
30. A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
31. Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
32. A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
33. Erratum: Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis
34. Analysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms
35. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility
36. Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry
37. Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum
38. Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
39. Effective Preparation of Plasmodium vivax Field Isolates for High-Throughput Whole Genome Sequencing
40. Comparative Ex Vivo Activity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparum and P. vivax
41. Expression of Plasmodium vivaxcrt-oIs Related to Parasite Stage but Not Ex VivoChloroquine Susceptibility
42. Potent Ex VivoActivity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparumand Plasmodium vivax
43. Contrasting Ex VivoEfficacies of “Reversed Chloroquine” Compounds in Chloroquine-Resistant Plasmodium falciparumand P. vivaxIsolates
44. Effective Preparation of Plasmodium vivaxField Isolates for High-Throughput Whole Genome Sequencing.
45. Comparative Ex VivoActivity of Novel Endoperoxides in Multidrug-Resistant Plasmodium falciparumand P. vivax
46. The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparumparasite resistance
47. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling
48. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose–Efficacy Modeling
49. Erratum for Brunschwig et al., “UCT943, a Next-Generation Plasmodium falciparumPI4K Inhibitor Preclinical Candidate for the Treatment of Malaria”
50. UCT943, a Next-Generation Plasmodium falciparumPI4K Inhibitor Preclinical Candidate for the Treatment of Malaria
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.